Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Letter to the Editor

Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April)

Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia

Authors

Mike Makris , Cedric Hermans

Key words: Cryoprecipitate, FVIII concentrate, Haemophilia, Transfusion transmitted infection, World Health Organisation
DOI: 10.2450/BloodTransfus.974
Hemostasis and thrombosis
Publication Date: 2025-01-21

Abstract

This letter to the editor challenges the inclusion of cryoprecipitate on the WHO list of essential medicines to treat haemophilia.

Downloads

pdf
Authors

Mike Makris - School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom

Cedric Hermans - Division of Haematology, Haemostasis and Thrombosis Unit, Saint-Luc University Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium

  • Abstract viewed - 1003 times
  • pdf downloaded - 235 times